Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
69581 | Glaukos Corp (6GJ.TG) | XGAT | US | 2023-12-31 | 6 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
69582 | Glaukos Corp (GKOS) | XNYS | US | 2023-12-31 | 1 day ago | USD | 108.69 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
69583 | GlaxoSmithKline Pharmaceuticals Ltd (500660.BO) | XBOM | IN | 2023-03-31 | 1 day ago | INR | 2,023.85 | 240.95 | 11.91% | 53.65 | 2.65% | Enterprising | 208.27 | 10.29% |
69584 | GlaxoSmithKline Pharmaceuticals Ltd (GLAXO.NS) | XNSE | IN | 2023-03-31 | 1 day ago | INR | 2,022.50 | 240.95 | 11.91% | 53.65 | 2.65% | Enterprising | 208.27 | 10.30% |
69585 | GlaxoSmithKline PLC (GS7A.F) | 2019-12-31 | 3 years ago | GBP | 0.00 | 7.38 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
69586 | GlaxoSmithKline PLC (GS7A.SG) | 2019-12-31 | 3 years ago | GBP | 0.00 | 7.38 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
69587 | GlaxoSmithKline SAE (BIOC.CA) | XCAI | EG | 2023-12-31 | 6 days ago | EGP | 30.13 | 14.61 | 48.50% | 15.24 | 50.57% | NCAV (Net-Net) | 15.24 | 50.57% |
69588 | Glen Burnie Bancorp (GLBZ) | XNAS | US | 2023-12-31 | 1 day ago | USD | 4.75 | 10.00 | 210.52% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
69589 | Glen Eagle Resources Inc (GER.NE) | NEOE | CA | 2022-12-31 | 4 months ago | CAD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
69590 | Glen Eagle Resources Inc (GER.TWO) | CA | 2021-12-31 | 1 year ago | CAD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |